2m 2m 2m 2m 2m 2m 2m
PHIO PHARMA (PHIO)
NASDAQ
$1.06+$0.02 (+1.92%)
Price as of Jun 23, 2026 7:59 PM EDT- $12.2MMarket Cap
- -51.83%1-Year Change
- BiotechnologyIndustry
PHIO PHARMA (PHIO)
$1.06+$0.02 (+1.92%)
PHIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.04 | ||
Change | +$0.02 (+1.94%) | ||
Open | $1.04 | ||
High | $1.07 | ||
Low | $1.04 | ||
Previous Close | $1.05 | ||
Volume | 283,355 | ||
30-Day Average Volume | 163,466 | ||
1-Week Change | -4.55% | ||
1-Month Change | -3.67% | ||
1-Year Change | -51.83% | ||
3-Year Change | -96.11% | ||
5-Year Change | -99.56% | ||
Fundamentals | |||
Shares Outstanding | 11.6M | ||
Total Assets | $17.4M | ||
Market Cap | $12.2M | ||
Enterprise Value | -$4.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.0M | ||
Free Cash Flow | -$4.0M | ||
EBIT | -$4.0M | ||
EBITDA | -$4.0M | ||
Net Working Capital | $16.5M | ||
EPS | -$0.34 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | N/A | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 9 | ||
Last Split Date | 07/05/2024 | ||
Earnings & Revenue